Variant report
Variant | esv1838765 |
---|---|
Chromosome Location | chr4:187093557-187100384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:187091730..187094624-chr4:187097179..187100415,3 | MCF-7 | breast: | |
2 | chr4:187098304..187101860-chr4:187110284..187112773,3 | K562 | blood: | |
3 | chr4:187092687..187094578-chr4:187097251..187099352,2 | MCF-7 | breast: | |
4 | chr4:187092687..187094578-chr4:187097251..187099352,2 | MCF-7 | breast: | |
5 | chr4:187092198..187094078-chr4:187111646..187113279,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ORAOV1P1 | TF binding region |
ENSG00000269302 | chromatin interactions |
ENSG00000251008 | chromatin interactions |
ENSG00000145476 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34932393 | chr4:187093616-187093617 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs547015586 | chr4:187093669-187093670 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs554642111 | chr4:187093670-187093671 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs566527252 | chr4:187093700-187093701 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs201679072 | chr4:187093719-187093720 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs574428212 | chr4:187093755-187093756 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs191336072 | chr4:187093803-187093804 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs183651082 | chr4:187093804-187093805 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs34809182 | chr4:187093856-187093857 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs139275845 | chr4:187093875-187093876 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs114689708 | chr4:187093877-187093878 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs576168093 | chr4:187093888-187093889 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs556855375 | chr4:187093889-187093890 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs188479173 | chr4:187093919-187093920 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs192467523 | chr4:187093962-187093963 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs146147580 | chr4:187093996-187093997 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs149979981 | chr4:187094047-187094048 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs184768637 | chr4:187094068-187094069 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs145165537 | chr4:187094140-187094141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565550446 | chr4:187094222-187094223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531210063 | chr4:187094288-187094289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111401250 | chr4:187094312-187094313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143649703 | chr4:187094377-187094378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530257642 | chr4:187094423-187094424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546728411 | chr4:187094504-187094505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201015854 | chr4:187094515-187094516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187979282 | chr4:187094547-187094548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538616074 | chr4:187094558-187094559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112813515 | chr4:187094576-187094577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571238455 | chr4:187094610-187094611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7685209 | chr4:187094621-187094622 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs557162050 | chr4:187094635-187094636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567346058 | chr4:187094653-187094654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377034486 | chr4:187094654-187094655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532635882 | chr4:187094692-187094693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553069203 | chr4:187094702-187094703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74466539 | chr4:187094716-187094717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191238209 | chr4:187094725-187094726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545049817 | chr4:187094741-187094742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558570046 | chr4:187094788-187094789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143624096 | chr4:187094791-187094792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541376608 | chr4:187094800-187094801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542000432 | chr4:187094802-187094803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560053842 | chr4:187094839-187094840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375908738 | chr4:187094847-187094848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs118139997 | chr4:187094873-187094874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563644916 | chr4:187094884-187094885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184387040 | chr4:187094893-187094894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35841069 | chr4:187094912-187094913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540739204 | chr4:187094921-187094922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187080000-187094000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr4:187080200-187094000 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
3 | chr4:187081000-187099200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr4:187082000-187095000 | Weak transcription | Fetal Brain Male | brain |
5 | chr4:187090200-187094800 | Weak transcription | Brain Hippocampus Middle | brain |
6 | chr4:187090600-187095000 | Weak transcription | Fetal Brain Female | brain |
7 | chr4:187092400-187094200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr4:187093200-187094000 | Enhancers | Duodenum Mucosa | Duodenum |
9 | chr4:187094000-187094200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
10 | chr4:187099200-187099600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |